Pharma-Bio Serv, Inc. (PBSV) stock
PBSVOTCServices-Management Consulting ServicesFiscal year ends October 31
$0.48+0.08 (+20.00%)
Close on Oct 19, 2026Market cap $11.00MP/E 48.0Yield –
Pharma-Bio Serv shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
Pharma-Bio Serv's shares outstanding was 23M at Jul 31, 2026. For fiscal 2025 it was 23M, down 0.1% from the year before. Over ten years it grew -0.2% a year on average. The highest annual figure on record is 24M in fiscal 2014.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | 23M | -0.1% |
| FY2024 | Oct 31, 2024 | 23M | -0.1% |
| FY2023 | Oct 31, 2023 | 23M | -0.1% |
| FY2022 | Oct 31, 2022 | 23M | -0.6% |
| FY2021 | Oct 31, 2021 | 23M | +0.5% |
| FY2020 | Oct 31, 2020 | 23M | -0.3% |
| FY2019 | Oct 31, 2019 | 23M | +0.1% |
| FY2018 | Oct 31, 2018 | 23M | -0.0% |
| FY2017 | Oct 31, 2017 | 23M | -0.4% |
| FY2016 | Oct 31, 2016 | 23M | -0.9% |
| FY2015 | Oct 31, 2015 | 23M | -1.2% |
| FY2014 | Oct 31, 2014 | 24M | +0.1% |
| FY2013 | Oct 31, 2013 | 24M | +3.1% |
| FY2012 | Oct 31, 2012 | 23M | +1.7% |
| FY2011 | Oct 31, 2011 | 23M | +0.8% |
| FY2010 | Oct 31, 2010 | 22M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026CQ2 2026 | Jul 31, 2026 | 23M | -0.1% |
| Q2 FY2026CQ1 2026 | Apr 30, 2026 | 23M | -0.1% |
| Q1 FY2026CQ4 2025 | Jan 31, 2026 | 23M | -0.2% |
| Q4 FY2025CQ3 2025 | Oct 31, 2025 | 23M | -0.0% |
| Q3 FY2025CQ2 2025 | Jul 31, 2025 | 23M | -0.1% |
| Q2 FY2025CQ1 2025 | Apr 30, 2025 | 23M | -0.1% |
| Q1 FY2025CQ4 2024 | Jan 31, 2025 | 23M | -0.1% |
| Q4 FY2024CQ3 2024 | Oct 31, 2024 | 23M | -0.2% |
| Q3 FY2024CQ2 2024 | Jul 31, 2024 | 23M | -0.1% |
| Q2 FY2024CQ1 2024 | Apr 30, 2024 | 23M | -0.2% |
| Q1 FY2024CQ4 2023 | Jan 31, 2024 | 23M | +0.1% |
| Q4 FY2023CQ3 2023 | Oct 31, 2023 | 23M | -0.1% |
| Q3 FY2023CQ2 2023 | Jul 31, 2023 | 23M | -0.2% |
| Q2 FY2023CQ1 2023 | Apr 30, 2023 | 23M | -0.4% |
| Q1 FY2023CQ4 2022 | Jan 31, 2023 | 23M | -0.9% |
| Q1 FY2022CQ4 2021 | Jul 31, 2022 | 23M | -0.8% |
| Q2 FY2022CQ1 2022 | Apr 30, 2022 | 23M | -0.6% |
| Q4 FY2021CQ3 2021 | Oct 31, 2021 | 23M | +0.2% |
| Q3 FY2021CQ2 2021 | Jul 31, 2021 | 23M | +0.6% |
| Q2 FY2021CQ1 2021 | Apr 30, 2021 | 23M | +0.8% |
| Q1 FY2021CQ4 2020 | Jan 31, 2021 | 23M | +0.7% |
| Q4 FY2020CQ3 2020 | Oct 31, 2020 | 23M | -0.3% |
| Q3 FY2020CQ2 2020 | Jul 31, 2020 | 23M | -0.0% |
| Q2 FY2020CQ1 2020 | Apr 30, 2020 | 23M | -0.2% |
| Q1 FY2020CQ4 2019 | Jan 31, 2020 | 23M | -0.4% |
| Q4 FY2019CQ3 2019 | Oct 31, 2019 | 23M | -0.1% |
| Q3 FY2019CQ2 2019 | Jul 31, 2019 | 23M | -0.2% |
| Q2 FY2019CQ1 2019 | Apr 30, 2019 | 23M | +0.0% |
| Q1 FY2019CQ4 2018 | Jan 31, 2019 | 23M | +0.2% |
| Q4 FY2018CQ3 2018 | Oct 31, 2018 | 23M | +0.1% |
| Q3 FY2018CQ2 2018 | Jul 31, 2018 | 23M | -0.1% |
| Q2 FY2018CQ1 2018 | Apr 30, 2018 | 23M | -0.2% |
| Q1 FY2018CQ4 2017 | Jan 31, 2018 | 23M | -0.1% |
| Q4 FY2017CQ3 2017 | Oct 31, 2017 | 23M | -0.2% |
| Q3 FY2017CQ2 2017 | Jul 31, 2017 | 23M | -0.1% |
| Q2 FY2017CQ1 2017 | Apr 30, 2017 | 23M | – |
| Q1 FY2017CQ4 2016 | Jan 31, 2017 | 23M | – |
| Q4 FY2016CQ3 2016 | Oct 31, 2016 | 23M | – |
| Q3 FY2016CQ2 2016 | Jul 31, 2016 | 23M | – |
See a number that looks wrong?